How to Help Your Patients Find Zyprexa in Stock: A Provider's Guide

Patients with schizophrenia or bipolar disorder who cannot access their medication face serious clinical risks. When a patient reports that they cannot fill their Zyprexa (olanzapine) prescription, the provider's response matters enormously. This guide gives you practical, actionable steps to help patients locate their medication quickly and safely.

Why Patients Can't Find Zyprexa: What You Need to Know

Oral olanzapine is not in a national FDA shortage in 2026, but that does not mean your patient can find it at their pharmacy. Common reasons include:

Generic manufacturer supply gaps (multiple manufacturers exist, but individual pharmacies may stock only one)

Dose-specific stocking issues (less-common doses like 7.5 mg or 2.5 mg may not be routinely stocked)

ODT (orally disintegrating tablet) formulations requiring advance orders at smaller pharmacies

IM injection formulation supply issues (documented shortage on ASHP tracker)

Step 1: Assess the Urgency

When a patient contacts you about a fill issue, first determine:

How many days of medication do they have left?

Are they currently stable on their current dose?

Have they already called multiple pharmacies, or just one?

A patient with 7+ days remaining has time to exhaust pharmacy options before intervention. A patient with 1-2 days remaining needs an immediate clinical response.

Step 2: Prescribing Strategies to Improve Fill Success

Several prescribing-level interventions can proactively reduce fill problems:

Prescribe 90-day supplies. Since olanzapine is not a controlled substance, most payers allow 90-day fills. Mail-order pharmacy through the patient's insurance plan is often covered at a lower co-pay and is not subject to local pharmacy stocking gaps.

Write "generic substitution permissible" on the prescription. Allow pharmacists to dispense from any FDA-approved generic manufacturer. This gives the pharmacist flexibility to order from an alternative supplier if their primary one is out.

Consider the ODT formulation for adherence-challenged patients. The orally disintegrating tablet (Zyprexa Zydis / generic olanzapine ODT) dissolves quickly in saliva without water and cannot be easily hidden — an important clinical advantage for supervised settings.

Avoid unnecessarily rare doses when clinically equivalent standard doses work. The 5 mg and 10 mg tablets are the most widely stocked. If a patient is stable on 7.5 mg, discuss whether two 5 mg tablets or alternative regimens might offer equivalent coverage and simpler dispensing.

Step 3: Direct the Patient to the Right Resources

Provide patients with a concrete plan rather than "try a few more pharmacies":

Recommend medfinder. medfinder calls pharmacies near the patient to check which ones can fill the prescription, then texts results to the patient. This eliminates the frustrating phone-around process.

Offer to send the prescription electronically to a pharmacy that has stock. Once a patient identifies a pharmacy with stock, e-prescribe directly to that location. Most EHR systems can send prescriptions to any pharmacy in the US.

Set up mail-order pharmacy. Help initiate the enrollment or coordinate with your care team or pharmacy staff. Most insurance plans require a new 90-day prescription — write it at the appointment.

Refer to patient assistance programs if cost is also a barrier. For uninsured patients, Eli Lilly's patient assistance program (Lilly Cares) and generic olanzapine with a GoodRx coupon (as low as $6.70) may help. See our full guide to Zyprexa savings programs for providers.

Step 4: Bridge Strategies if the Patient Is About to Run Out

If the patient cannot wait 24-48 hours for a new supply:

Prescribe an available strength as a bridge. If they take 10 mg and only 5 mg is available, prescribe two 5 mg tablets per day.

Check your sample closet. Eli Lilly has provided samples historically — check with your medical representative or your sample inventory.

If transitioning to a temporary alternative is clinically necessary, use a structured cross-taper. Never instruct a patient to simply stop and start a new antipsychotic without a tapering plan.

Build Medication Access Into Your Standard of Care

Rather than reacting to access crises one at a time, consider embedding pharmacy access check-ins into your routine appointments for patients on antipsychotics. Ask: "Where do you fill this? Have you had any trouble getting it recently?" Early identification of refill barriers prevents last-minute emergencies.

medfinder's provider tools are designed to support exactly this workflow. Learn more at medfinder.com/providers.